These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25867045)

  • 41. Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response.
    Babcock JT; Nguyen HB; He Y; Hendricks JW; Wek RC; Quilliam LA
    J Biol Chem; 2013 May; 288(22):15687-98. PubMed ID: 23612979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet-derived growth factor/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1/Tsc2-dependent inhibition of TORC1.
    Tran TA; Kinch L; Peña-Llopis S; Kockel L; Grishin N; Jiang H; Brugarolas J
    Mol Cell Biol; 2013 Oct; 33(19):3762-79. PubMed ID: 23878397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of didemnin B in advanced colorectal cancer.
    Jones DV; Ajani JA; Blackburn R; Daugherty K; Levin B; Patt YZ; Abbruzzese JL
    Invest New Drugs; 1992 Aug; 10(3):211-3. PubMed ID: 1428730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer.
    Faber AC; Farago AF; Costa C; Dastur A; Gomez-Caraballo M; Robbins R; Wagner BL; Rideout WM; Jakubik CT; Ham J; Edelman EJ; Ebi H; Yeo AT; Hata AN; Song Y; Patel NU; March RJ; Tam AT; Milano RJ; Boisvert JL; Hicks MA; Elmiligy S; Malstrom SE; Rivera MN; Harada H; Windle BE; Ramaswamy S; Benes CH; Jacks T; Engelman JA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1288-96. PubMed ID: 25737542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
    Rhyasen GW; Hattersley MM; Yao Y; Dulak A; Wang W; Petteruti P; Dale IL; Boiko S; Cheung T; Zhang J; Wen S; Castriotta L; Lawson D; Collins M; Bao L; Ahdesmaki MJ; Walker G; O'Connor G; Yeh TC; Rabow AA; Dry JR; Reimer C; Lyne P; Mills GB; Fawell SE; Waring MJ; Zinda M; Clark E; Chen H
    Mol Cancer Ther; 2016 Nov; 15(11):2563-2574. PubMed ID: 27573426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of protein synthesis by didemnins: cell potency and SAR.
    Ahuja D; Geiger A; Ramanjulu JM; Vera MD; SirDeshpande B; Pfizenmayer A; Abazeed M; Krosky DJ; Beidler D; Joullié MM; Toogood PL
    J Med Chem; 2000 Nov; 43(22):4212-8. PubMed ID: 11063617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways.
    Selvarajah J; Nathawat K; Moumen A; Ashcroft M; Carroll VA
    Cell Death Dis; 2013 Oct; 4(10):e865. PubMed ID: 24136229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crystal and molecular structure of didemnin A, an antiviral depsipeptide.
    Hossain MB; Van Der Helm D; Antel J; Sheldrick GM; Weinheimer AJ; Sanduja SK
    Int J Pept Protein Res; 1996; 47(1-2):20-7. PubMed ID: 8907495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibition.
    Shi H; Kong X; Ribas A; Lo RS
    Cancer Res; 2011 Aug; 71(15):5067-74. PubMed ID: 21803746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis.
    Zhao Y; Xiong X; Jia L; Sun Y
    Cell Death Dis; 2012 Sep; 3(9):e386. PubMed ID: 22951983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical and cellular effects of didemnins A and B.
    Crampton SL; Adams EG; Kuentzel SL; Li LH; Badiner G; Bhuyan BK
    Cancer Res; 1984 May; 44(5):1796-801. PubMed ID: 6713383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
    Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
    Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress.
    Lin A; Yao J; Zhuang L; Wang D; Han J; Lam EW; Gan B
    Oncogene; 2014 Jun; 33(24):3183-94. PubMed ID: 23851496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
    Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC
    Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapamycin inhibits mTORC1, but not completely.
    Thoreen CC; Sabatini DM
    Autophagy; 2009 Jul; 5(5):725-6. PubMed ID: 19395872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of protein synthesis by didemnin B is not sufficient to induce apoptosis in human mammary carcinoma (MCF7) cells.
    Beidler DR; Ahuja D; Wicha MS; Toogood PL
    Biochem Pharmacol; 1999 Sep; 58(6):1067-74. PubMed ID: 10509759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
    J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis.
    Grubb DR; Ly JD; Vaillant F; Johnson KL; Lawen A
    Oncogene; 2001 Jul; 20(30):4085-94. PubMed ID: 11494136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo.
    Xie H; Zhu F; Huang Z; Lee MH; Kim DJ; Li X; Lim DY; Jung SK; Kang S; Li H; Reddy K; Wang L; Ma W; Lubet RA; Bode AM; Dong Z
    Carcinogenesis; 2012 Sep; 33(9):1814-21. PubMed ID: 22798378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.